Zomedica Expands International Reach with CE Certification for VetGuardian(R) System
Key approval paves way for European expansion, tapping into a $4 billion vet services market ANN ARBOR, MI / ACCESSWIRE / May 6, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering …
Key approval paves way for European expansion, tapping into a $4 billion vet services market
ANN ARBOR, MI / ACCESSWIRE / May 6, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostics and therapeutic products for equine and companion animals, today announced that it has received CE certification for its VetGuardian remote contactless monitoring system. The CE marking confirms that the VetGuardian system meets all EU health, safety, and environmental protection standards. Importantly, this significant milestone expands the market size for VetGuardian and enhances access for internationally based veterinarians seeking advanced solutions for their patients.
"Receiving CE certification is a testament to the safety and performance of our VetGuardian monitor, allowing us to bring this advanced technology to veterinary professionals across the European Union and beyond," stated Tony Blair, Chief Operating Officer of Zomedica. "This milestone not only expands our market potential but also provides veterinarians with a tool that enhances patient care and operational efficiency."
The VetGuardian system utilizes state-of-the-art radar technology for contactless monitoring of vital signs in animals, promoting stress-free care and saving time during patient monitoring, enabling optimized workflow and improved outcomes.
"The CE mark is a green light for us to accelerate our global expansion with one of our fastest-growing products," said Kevin Klass, SVP sales at Zomedica. "We're already receiving inquiries from customers around the world, and we can now meet this growing demand head-on."
The European veterinary market was valued at $4.0 billion in 2022 and is projected to reach $5.4 billion by 2027, according to data from EuroDev.
"The completion of CE certification for the VetGuardian monitor marks a significant milestone for Zomedica, opening new avenues of growth as we continue to drive innovation in the veterinary health sector," stated Larry Heaton, CEO of Zomedica. "With expanded market access and enhanced credibility, Zomedica remains at the forefront of delivering positive change in animal healthcare."